arrow
D

Dariush Etemadmoghadam

Melbourne Health
H指数:50
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Colorectal cancer RISk Prediction (CRISP) trial: a randomised controlled trial of a decision support tool for risk-stratified colorectal cancer screening

结直肠癌风险预测 (CRISP) 试验: 风险分层结直肠癌筛查决策支持工具的随机对照试验

2023-01-237
OAAI
Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities

低级别浆液性卵巢癌的基因组分析,以确定关键驱动因素和治疗脆弱性

2020-10-2869
OAAI
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing

使用全基因组测序对2,658种人类癌症中的色素病进行综合分析

2020-02-05292
OAAI
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

全基因组的泛癌症分析确定了由LINE-1反转录转座促进的驱动程序重排

2020-02-05252
OAAI
Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
2019-07-0129
OAAI
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion
2019-04-0243
OA
EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas
2017-08-1460
OAAI
Using molecularly characterized patient-derived models to delineate underlying drivers and vulnerabilities of epithelial ovarian cancer

使用分子表征的患者衍生模型来描述上皮性卵巢癌的潜在驱动因素和脆弱性

2014-12-120
PRE
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts

人类高级浆液性卵巢癌患者来源的异种移植物中铂反应的分子相关性

2014-01-24125
OA
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
2012-12-21510
OA
LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin
2012-08-1497
OAAI
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes
2012-07-0277
OAAI